Priti Tagde, Kalpana Nagpal, Giriraj T Kulkarni
firstname.lastname@example.org , email@example.com , firstname.lastname@example.org
Priti Tagde1, Kalpana Nagpal1*, Giriraj T Kulkarni2*
1Amity Institute of Pharmacy, Amity University, Uttar Pradesh, Noida 201301 (UP).
2Gokaraju Rangaraju College of Pharmacy, Bachupally, Hyderabad 500090 (Telangana).
Volume - 15,
Issue - 9,
Year - 2022
Raloxifene (RLX) and Curcumin (CUR) are used for the treatment of breast cancer. Its combination is chosen because of their synergistic therapeutic potential, which helps to reduce drug-related toxicities while increasing therapeutic efficacy. A simple, sensitive, accurate and specific technique for determining retention time by employing reverse-phase high-performance liquid chromatography for simultaneous estimation of both the drugs was developed as well validated for the analysis on their particular wavelength. The separation was performed on an RP C-18 Column (EC 250/4 neucleosil 100-10) with column dimensions 250mm x 4.60mm, 10mM using mobile phase Potassium dihydrogen phosphate: acetonitrile (pH 3.0 with Orthophosphoric acid) in the ratio of 20:80 v/v and flow rate of 1.0min/mL. The specificity, linearity range, accuracy, sensitivity, robustness, precision, and ruggedness of the method were all determined. The analyte's peaks were found to be well resolved, and two different RTs for RLX and CUR were observed. Over a concentration range of 1-5?g/ml, RLX and CUR calibration curves were shown to be linear. All of the technique validation criteria were within acceptable limits. For inter- and intra-day precision, the relative standard deviation (%RSD) was found to be <2%.
Cite this article:
Priti Tagde, Kalpana Nagpal, Giriraj T Kulkarni. A new Validated RP-HPLC Method for simultaneous quantification of Raloxifene and Curcumin. Research Journal of Pharmacy and Technology. 2022; 15(9):4218-5. doi: 10.52711/0974-360X.2022.00709
Priti Tagde, Kalpana Nagpal, Giriraj T Kulkarni. A new Validated RP-HPLC Method for simultaneous quantification of Raloxifene and Curcumin. Research Journal of Pharmacy and Technology. 2022; 15(9):4218-5. doi: 10.52711/0974-360X.2022.00709 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-9-69
1. Goldstein, S. R: Update on raloxifene to prevent endometrial-breast cancer. European Journal of Cancer. 36, 54-56. https://doi.org/10.1016/S0959-8049(00)00227-6
2. Martino, S, Cauley, J.A, Barrett-Connor, E, Powles, T.J, Mershon, J, Disch, D, Secrest, R.J and Cummings, S.R: Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. Journal of the National Cancer Institute 2004; 96(23), 1751-1761.https://doi.org/10.1093/jnci/djh319
3. Pavithra, D. C, and Sivasubramanian, L : New spectrophotometric determination of raloxifene hydrochloride in tablets. Indian Journal of Pharmaceutical Sciences. 2006; 68(3).https://doi.org/10.4103/0250-474X.26687
4. Rao, G., Rao, V.S. and Ramakrishna, K: Quality by Design Approach for the Development and Validation of LC method for the Estimation of in-Vitro release of Raloxifene hydrochloride in Dosage Formulation.Research J. Pharm. and Tech. 2015; 8(11), 1487-1494. 10.5958/0974-360X.2015.00266.8
5. Sandur, S.K, Pandey, M.K, Sung, B, Ahn, K.S, Murakami, A, Sethi, G, Limtrakul, P, Badmaev, V and Aggarwal, B.B : Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism.Carcinogenesis 2007; 28(8), 1765-1773. https://doi.org/10.1093/carcin/bgm123
6. Francis, S.P. and Srinivasan, M; Enhancing the Bioavailability of a Natural Product Curcumin to increase the Therapeutic Efficacy by a Novel Formulation Technology. Research J. Pharm. and Tech. 2019; 12(6), 2615-2620.
7. Jayandran, M., Haneefa, M.M. and Balasubramanian, V: Synthesis, Characterization and Antimicrobial Activities of Turmeric Curcumin and Curcumin Stabilized Zinc Nanoparticles - A Green Approach. Research J. Pharm. and Tech. 2015; 8(4), 445-451.
8. Suman Saha, Amit Roy, Sanjib Bahadur, Ananta Choudhury. Bioenhamcement of Curcumin by Dual approach. Research J. Pharm. and Tech. 2016; 9(8):1059-1063.
9. Gujar, Ashwini V, Anand B Mundada, and Atul A. Shirkhedkar: Analytical Review on Raloxifene-An Estrogen Receptor Modulator in Different Pharmaceutical Formulations and Biological Fluids 2017.
10. Chen, T.W, Merlin, J.P, Chen, S.M, Anandaraj, S, Elshikh, M.S, Tseng, T.W, Wang, K, Qi, D and Jiang, J: Sonochemical synthesis and fabrication of neodymium sesquioxide entrapped with graphene oxide based hierarchical nanocomposite for highly sensitive electrochemical sensor of anti-cancer (raloxifene) drug. Ultrasonics Sonochemistry 2020; 64, 104717.
11. Kang, N.W, Kim, M.H, Sohn, S.Y, Kim, K.T, Park, J.H, Lee, S.Y, Lee, J.Y and Kim, D.D: Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Biomaterials 2018; 182, 245-258.
12. Thejeswari, Y. and Kumar, S.R: Amelioration and Affirmation for the Assessment of Curcumin in API and Ayurvedic Herbal Formulation Haridra Capsule by UFLC Discrete Method. Asian Journal of Research in Chemistry. 2013; 6(9), 1051.
13. Zinjad, P, Gondhale, P, Kulkarni, S, Musmade, B, Bhope, S and Padmanabhan, S: Development and validation of HPLC-UV method for the quantitative analysis of carcinogenic organic impurities and its isomers in the sodium polystyrene sulfonate polymer. Acta Chromatographica 2021; 33(2), 162-169. https://doi.org/10.1556/1326.2020.00774
14. Shukla, R: Simple UV method development and Validation for the estimation of Raloxifene in marketed formulation. International Journal of Pharmaceutics and Drug Research 2019; 7 (2),85-91
15. Raouf, A: Development and validation of analytical methods for the determination of some drugs used for musculoskeletal system Disorders and Osteoporosis Therapy. CU Theses 2019.
16. Kotha, R.R and Luthria, D.L: Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules 2019; 24(16), 2930. https://doi.org/10.3390/molecules24162930
17. Pelikh, O, Pinnapireddy, S.R and Keck, C.M: Dermal Penetration Analysis of Curcumin in an ex vivo Porcine Ear Model using Epifluorescence Microscopy and Digital Image Processing. Skin Pharmacology and Physiology 2021; 34 (2), 1-19. https://doi.org/10.1159/000514498
18. Srivastava, M. ed: High-performance thin-layer chromatography (HPTLC). Springer Science and Business Media 2010
19. da Silva-Buzanello, R.A, Ferro, A.C, Bona, E, Cardozo-Filho, L, de Araújo, P.H.H, Leimann, F.V and Gonçalves, O.H: Validation of an Ultraviolet–visible (UV–Vis) technique for the quantitative determination of curcumin in poly (l-lactic acid) nanoparticles. Food Chemistry 2015; 172, 199104.https://doi.org/10.1016/j.foodchem.2014.09.016
20. Jangle, R.D and Thorat, B.N; Reversed-phase high-performance liquid chromatography method for analysis of curcuminoids and curcuminoid-loaded liposome formulation. Indian Journal of Pharmaceutical Sciences 2013; 75 (1), 60. https://doi.org/10.4103/0250-474X.113555
21. Zambre, A.P, Kulkarni, V.M, Padhye, S, Sandur, S.K and Aggarwal, B.B: Novel curcumin analogs targeting TNF-induced NF-κB activation and proliferation in human leukemic KBM-5 cells. Bioorganic and Medicinal Chemistry 2006: 14(21), 7196-7204.https://doi.org/10.1016/j.bmc.2006.06.056
22. Pratik J. Purohit, Pankaj P. Kapupara, Ketan V. Shah. Development and Validation of Analytical Method for Simultaneous Estimation of Curcumin and Gallic Acid in Different Polyherbal Formulations by HPLC. Research J. Pharm. and Tech. 2014; 7(7), 749-753.
23. K. Vijaya Sri, M. Anusha, S. Ravinder Reddy. A Rapid RP-HPLC Method development and Validation for the Analysis of Linagliptinin Bulk and Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 5(1): Jan.- March 2015; Page 16-20.Huang, C, Lu, H.F, Chen, Y.H, Chen, J.C, Chou, W.H and Huang, H.C : Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and–independent apoptosis via Smad or Akt signaling pathways in HOS cells. BMC Complementary Medicine and Therapies 2020; 20(1), 1-11.
24. Guideline, I.H.T: Validation of analytical procedures: text and methodology. Q2 (R1) 2005; 1(20), 05.
25. Palatheeya, S., Rao, K.H. and Rao, B.V: A Modified stability Indicating liquid Chromatographic method Development and validation for the Estimation of clopidogrel and Rosuvastatin in bulk and Tablet Dosage Forms. Research J. Pharm. and Tech. 2020; 13(3), 1324-1328.
26. Peraman, R., Bhadraya, K., Reddy, Y.P., Reddy, C.S. and Lokesh, T: A rapid RP-HPLC method development and Validation for the Analysis of Linagliptinin Bulk and Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 2015; 5(1), 16-20.
27. Konidala, S.K., Babu, P.V. and Ranjitha, K.S.D: RP-HPLC Method Development and Validation for the Simultaneous Estimation of Sitagliptin and Simvastatin in Pharmaceutical Formulation. Asian J. Pharm. Ana. 2016; 6(2), 68-76.
28. B. Rao, B.V., Vijetha, P., Vidyadhara, S. and Kavitha, K: A Novel RP-HPLC Method Development and Validation for the Determination of Pioglitazone and Glimepiride in Bulk and Pharmaceutical Formulations. Asian J. Pharm. Ana. 2017; 7(3), 145-150.
29. Saravanan, G. and Latha, C.S: Development and validation of RP-HPLC method for simultaneous estimation of Tapentadol and Paracetamol in bulk and combined dosage form. Asian Journal of Research in Chemistry 2014; 7(2), 220-224.
30. Patel, A.B: Analytical Method Validation: Collation between International Guidelines. Asian J. Research Chem. 2017; 10(6), 857-866.